Vitamin K-dependent carboxylase activity has been demonstrated in the crude microsomal fraction of the intima of bovine aortae. The procedure for the isolation of vessel wall carboxylase is a slight modification of the general preparation procedure for tissue microsomes. The highest activity of the non-hepatic enzyme was observed at 25°C and hardly any NADH-dependent vitamin K reductase could be demonstrated. The optimal reaction conditions for both vessel wall as well as liver carboxylase were similar: 0.1 M-NaCl/0.05 MTris/HCl, pH 7.4, containing 8 mM-dithiothreitol, 0.4% 3-[(3-cholamidopropyl) 
INTRODUCTION
Vitamin K-dependent carboxylase is a microsomal enzyme system, discovered in rat liver more than 10 years ago (Esmon et al., 1975) . Since then, carboxylase activity has been demonstrated in the livers of a wide variety of species, including man (Suttie et al., 1979; Vermeer et al., 1982a; Soute et al.,. 1982 ). The enzyme is involved in the post-translational carboxylation of distinct glutamic acid (Glu) residues into 4-carboxyglutamic acid (Gla) residues (Suttie, 1980; Vermeer, 1984) . For many years it has been thought that the carboxylating enzyme system was only restricted to the liver, but recently carboxylase has also been detected in other tissues such as lung, kidney, spleen, testis and bone (Buchtal & Bell, 1983; Vermeer et al., 1982b) . Whereas it is known that hepatic carboxylase is involved in the production of a number of proteins involved in blood coagulation, the importance of the non-hepatic systems is far less understood.
In the liver three metabolites of vitamin K have been identified: vitamin K quinone (K), vitamin K hydroquinone (KH2) and vitamin K epoxide (KO). Of these three metabolites KH2 is the coenzyme for carboxylase and its oxidation to KO probably provides the energy required for the carboxylation reaction. KO is then reduced to K and KH2 by two or more reductases. In this way there is a cyclic interconversion of vitamin K metabolites resulting in a constant supply of KH2, so that the coenzyme can be re-used many times. DTT may serve in vitro as a reducing cofactor for these reductases, but the physiological cofactor has not yet been identified (Wallin et al., 1978) . Like the carboxylase, also the reductases are found in the microsomal fraction of tissue homogenates, where they seem to occur closely associated with carboxylase.
In this paper we describe the isolation and partial characterization of a non-hepatic vitamin K-dependent carboxylase present in the microsomal fractions of the intima of bovine aortae. Unfortunately the reaction product of this vessel wall carboxylase has not yet been identified. It might be related to the Gla-containing protein found in hardened atherosclerotic plaque (Levy et al., 1979 (Levy et al., , 1986 . Since a number of non-hepatic Gla-containing proteins are found in calcified tissues (Hauschka et al., 1976; Lian et al., 1977) , it might be possible that the product of vessel wall carboxylase plays a role in the deposition of calcium salts in the vessel wall during atherosclerosis.
MATERIALS AND METHODS Chemicals
Vitamin K1 (Konakion) was obtained from HoffmannLa Roche (Basel, Switzerland) and chemically reduced into the hydroquinone form (Vermeer et al., 1982a) . Warfarin, dithiothreitol, CHAPS and Triton X-100 were purchased from Sigma, and the synthetic substrate Phe-Leu-Glu-Glu-Leu (FLEEL) was from Vega Biochemicals (Tucson, AZ, U.S.A. 
Preparation of liver microsomal carboxylase
Crude microsomes were prepared from the liver of normal cows as described earlier (Vermeer et al., 1982a) . The microsomes obtained were suspended in buffer A [0.5 M-NaCl/0.05 M-Tris/HCl (pH 7.4)/1 mM-EDTA/ 20% (v/v) ethylene glycol] to a final protein concentration of 10 mg/ml. The preparations were kept at -80°C until use.
Preparation of vessel wall carboxylase
Bovine aortae were obtained from normal cows within 1 h after slaughter and were quickly cooled in ice-cold buffer B [0.25 M-sucrose/0. 1 M-NaCl/0.05 M-Tris/HCl (pH 7.4)/20% (v/v) ethylene glycol]. The aortae were prepared free from media and adventitia and subsequently homogenized in buffer B using a high-speed homogenizer (Breda Scientific). A 20% homogenate (w/v) was used for the preparation of the crude microsomal fraction (Vermeer et al., 1982a) . It was observed that during the centrifugation at 10000 g of the homogenate at 4°C, the carboxylating enzyme was coprecipitated with collagen, resulting in a hardly detectable carboxylase activity in the microsomal fraction. Elevation ofthe temperature to 20°C during the centrifugation at 10000 g could solve this problem. After one wash the obtained microsomal fraction was suspended in buffer A to a concentration of 10 mg of protein/ml, frozen in liquid N2 and stored at -80°C until use.
Measurement of carboxylase activity
Unless stated otherwise, the vitamin K-dependent incorporation of '4CO2 was measured by incubating reaction mixtures (0.25 ml) in buffer A containing: 1.0 mg of microsomal protein and 0.01 mCi of NaH14CO3. The concentrations of exogenous substrates were as indicated. The optimal reaction conditions for the two enzymes were similar: 0.1 M-NaCl/0.05 M-Tris/ HCI, pH 7.4, containing 8 mM-DTT, 0.4% CHAPS, 2 M-(NH4)2SO4 and 0.4 mM-vitamin K hydroquinone, which was the last compound added to the reaction mixture. After sealing the tubes the mixtures were incubated at 25°C and at the indicated times the reaction was stopped by adding 2 ml of 5% (w/v) trichloroacetic acid. Subsequently traces of non-bound label were removed by degassing the samples at elevated temperatures for 3 min, before 10 ml of Atomlight was added. The samples were counted in a Beckman LS 1801 scintillation counter.
Preparation of substrates Osteocalcin was prepared from bovine bone and partly purified by batchwise adsorption to QAE-Sephadex in 0.15 M-NaCl/0.02 M-Tris/HCI (pH 7.4) followed by a stepwise elution with 1 M-NaCl, desalting, thermal decarboxylation and purification by preparative h.p.l.c. . Decarboxylated sperm Glaprotein (from human sperm) was prepared as described earlier . Descarboxyprothrombin fragment 13-29 was prepared by the proteolytic cleavage ofpurified bovine descarboxyprothrombin with subtilisin and purified with the aid of ion-exchange and sizeexclusion chromatography (Soute et al., 1981) .
Determination of apparent K. values
The reaction mixtures, containing various substrate concentrations, were incubated for different time intervals. For the determination of the kinetic constants, the period was chosen during which the reaction rates were linear. The data obtained in the absence of substrates were subtracted from those obtained in the presence of the substrate. The inverse of the initial reaction rates thus obtained was plotted against the inverse substrate concentrations. From the resulting Lineweaver-Burk plot, the apparent Michaelis constant (Km) was calculated according to the method of Eisenthal & Cornish-Bowden (1974) .
Other methods
Protein concentrations were determined as described by Sedmak & Grossberg (1977) . Decarboxylation of Gla-containing proteins was performed according to Poser & Price (1979) .
RESULTS
Once having succeeded in preparing in a reproducible way an active microsomal fraction from vessel wall, we wanted to characterize this vitamin K-dependent carboxylating enzyme system. In the first place we determined the optimal reaction conditions. These were similar for the hepatic and non-hepatic carboxylase (see the Materials and methods section). The carboxylase can be extracted from the crude microsomes of bovine aortae with the aid of detergents. The zwitterionic detergent CHAPS appeared to be a better detergent than the non-ionic Triton X-100 (results not shown). These findings are in agreement with the data obtained from earlier studies performed with liver carboxylase (Girardot & Johnson, 1982 The carboxylating enzyme system from the vessel wall shows the highest activity at 25°C and at this temperature the reaction rate was constant for 2 h (Fig.  1) . On the other hand, carboxylase activity was hardly measurable at 37°C, which indicates that in vitro the enzyme is quickly destroyed at this temperature. Because of these results all experiments described below were performed at 25°C using an incubation time of 2 h.
In the next experiments we have compared the carboxylating enzyme system from the vessel wall with that from the liver. Besides vitamin K hydroquinone, also vitamin K quinone could be used as a coenzyme for carboxylase from both types oftissue (results not shown). This demonstrates that, like the liver enzyme, also vessel wall carboxylase is associated with a reducing enzyme system. Dithiols such as DTT proved to be the most effective cofactor in vitro for these reductases. Since it is well known that in liver the DTT-dependent reductase is the site of action of vitamin K antagonists like warfarin, we have compared the sensitivity for this drug of the carboxylase/reductase enzyme systems from liver and vessel wall, using vitamin K quinone as a coenzyme. As is shown in Fig. 2 , both systems are, at least in vitro, inhibited to a similar degree.
We have also tried to detect the NADH-dependent vitamin K reductase in the vessel wall preparation, since its presence in a number of tissues has been reported (Wallin et al., 1978) . In these experiments again we used vitamin K quinone instead of the hydroquinone and DTT was replaced by NADH (2 mM). It turned out that under the assay conditions used here the NADHmediated carboxylation was low relative to the dithiol- supported reaction, both in hepatic as well as in non-hepatic microsomes (less than 5%).
Although we had not been able to detect differences between the vitamin K-binding sites of the two types of enzyme, it might still be possible that differences might be found at the substrate-binding sites. We have investigated this possibility by measuring the apparent kinetic constants of substrates of various origins in hepatic and non-hepatic microsomal fractions. Although we are aware of the complication that both, liver as well as vessel wall, carboxylases have not been purified completely, sufficient information can be obtained from these systems when the appropriate controls are made. For the determination of the kinetic constants, the reaction mixtures were incubated for 60 min. During this period the reaction rates were linear. The data obtained in the absence of vitamin K hydroquinone were subtracted from those obtained in the presence of vitamin K hydroquinone. The data obtained in the absence of substrates were subtracted from those obtained in the presence of the substrate. The following carboxylatable substrates were available: the pentapeptide FLEEL, decarboxylated osteocalcin (from bovine bone), decarboxylated fragment 13-29 (which is composed of the amino acid residues 13-29 in bovine descarboxyprothrombin) and decarboxylated sperm Gla-protein (from human sperm). The apparent Km values for these four substrates were measured in the two carboxylating enzyme systems and the results of these experiments are summarized in Table 1 . It is evident that d-osteocalcin is a good substrate for liver carboxylase and to a lesser degree also for vessel wall carboxylase. The apparent Km values for both substrates are much lower than those observed for the pentapeptide, which are in the millimolar range. It was not possible to measure the apparent Km values for fragment 13-29 and for d-sperm Gla-protein in vessel wall carboxylase, since even at high concentrations these substrates were carboxylated to a negligible degree.
It must be pointed out, however, that these studies were performed with equal amounts of microsomal protein. Since the enzyme activity per mg of protein is higher in microsomes from liver than in those from vessel wall, dissimilar amounts of carboxylase activity were Vol. 245 
DISCUSSION
In a previous study it has been demonstrated that the vitamin K-dependent carboxylases from the liver, kidney, lung and testis may be regarded as a group of isoenzymes, which mainly differ in their substrate specificity . In this paper we report the isolation and partial characterization of the vitamin K-dependent carboxylase from bovine aortae. The enzyme is, as in other tissues, located in the microsomal fraction of the tissue homogenate. We have investigated whether the non-hepatic enzyme is comparable with hepatic carboxylase or whether also in this case differences might exist between both enzymes.
For the isolation of vessel wall carboxylase the general preparation procedure for tissue microsomes had to be slightly modified. It was found that, during the low-speed centrifugation at 4°C of the collagen-rich vessel wall homogenate, carboxylase was co-precipitated with the collagen, resulting in a hardly detectable carboxylase activity in the microsomal fraction. By working quickly at 20°C this problem could be solved. The resulting washed microsomes were solubilized and contained vitamin K-dependent carboxylase as well as DTTdependent reductase.
In a first set of experiments we have compared the liver and vessel wall carboxylase/reductase systems with respect to their sensitivity towards warfarin. It turned out that both enzyme systems are inhibited in vitro by the drug to a more or less similar degree. This is in agreement with earlier experiments in vitro with other non-hepatic microsomal preparations (Soute et al., 1982; Vermeer, 1984) and with experiments in vivo, in which it was shown that the oral administration of low doses of warfarin to rats induces the accumulation of noncarboxylated precursor proteins in the microsomal fraction of hepatic as well as of non-hepatic tissues (Roncaglioni et al., 1983) .
In a second set of experiments we have compared the affinity of the two carboxylating systems towards different substrates. Four substrates were available: the pentapeptide FLEEL, d-osteocalcin, d-fragment 13-29 and d-sperm Gla-protein. It turned out that the latter two substrates were not carboxylated to a significant extent by vessel wall carboxylase. In an earlier report, in which we have compared carboxylase from liver, lung, kidney and testis, we have shown that all substrates were carboxylated by these enzymes, but that the carboxylases had a preference for either d-fragment 13-29 or d-sperm Gla-protein . Vessel wall carboxylase is different from the former enzymes, because only FLEEL and d-osteocalcin are carboxylated, whereas the other substrates are not recognized at all.
Unfortunately the reaction product of vessel wall carboxylase has not yet been identified. It might be related to the Gla-containing protein found in hardened atherosclerotic plaque (Levy et al., 1979 (Levy et al., , 1986 , but this is still uncertain at the moment. Since many non-hepatic Gla-containing proteins are found in various calcified tissues, the product of vessel wall carboxylase might play a role in the deposition of calcium salts in the vessel wall during atherosclerosis. From our observations it seems likely that the vitamin K-dependent enzyme system from vessel wall is similarly sensitive to warfarin as is the liver enzyme and therefore it cannot be excluded that, in patients undergoing oral anticoagulant therapy, which is meant to reduce the degree of carboxylation of their blood coagulation factors, also the products of vessel wall carboxylase are synthesized in an undercarboxylated form. Whether this effect has any clinical relevance remains to be awaited, however.
